Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUSERELIN for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 8 adverse event reports in the FDA FAERS database where BUSERELIN was used for Prostate cancer.

Most Reported Side Effects for BUSERELIN

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 14 20.6% 0 12
Alanine aminotransferase increased 12 17.7% 0 12
Aspartate aminotransferase increased 12 17.7% 0 12
Blood creatine phosphokinase increased 12 17.7% 0 12
Blood lactate dehydrogenase increased 12 17.7% 0 12
Gamma-glutamyltransferase increased 12 17.7% 0 12
Muscular weakness 12 17.7% 0 12
Product prescribing error 12 17.7% 0 12
Pyrexia 12 17.7% 0 12
Abdominal distension 5 7.4% 0 5
Ascites 5 7.4% 0 5

Other Indications for BUSERELIN

Product used for unknown indication (18) In vitro fertilisation (15)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

BUSERELIN Full Profile All Prostate cancer Drugs BUSERELIN Demographics BUSERELIN Timeline